Sofosbuvir impurity I, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI-7977) is an inhibitor of HCV RNA replication, demonstrates potent anti-hepatitis C virus activity.
Form:Solid
IC50& Target:HCV
Spécifications
Mécanismes biochimiques et physiologiques
Sofosbuvir impurity I, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI-7977) is an inhibitor of HCV RNA replication, demonstrates potent anti-hepatitis C virus activity.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
No vendor-tested biological assay protocols are provided for this item. As a chemical reference standard, typical analytical workflows include (general guidance):
Stock preparation: Dissolve a known mass in a suitable solvent (e.g., DMSO, MeOH, MeCN) to prepare a primary stock; record exact mass and volume for gravimetric accuracy. Final solvent choice should be verified experimentally for this item.
Calibration: Prepare serial dilutions to cover the expected quantitation range (e.g., 0.1–100 µg/mL for HPLC-UV; ng/mL–µg/mL for LC–MS/MS). Use amber vials if photo-lability is suspected.
System suitability: Inject standard to assess retention, resolution from sofosbuvir peak, tailing factor, and plate count under intended chromatographic conditions.
Validation checkpoints: Evaluate linearity, accuracy (spike recovery), precision (intra-/inter-day), LOD/LOQ, and robustness per ICH Q2(R2).
All details should be adapted to the confirmed structure and properties from the CoA/SDS.
Biological Roles
This product is a small-molecule impurity standard and is not intended for biological interrogation. No biological function, pathway involvement, or target engagement is specified.
General note (not item-specific): Sofosbuvir-related impurities are structurally related to a nucleotide prodrug, but impurity standards themselves are supplied solely for analytical and chemical research. They should not be used in cellular or in vivo systems unless appropriate risk assessments and approvals are in place, and no biological claims should be inferred from their association with the parent API.
Buffer Applications
Not typically applicable. This item is an organic impurity standard rather than a buffering reagent. If used in analytical contexts involving buffers (e.g., LC–MS mobile phases), choose MS-compatible volatile buffers (ammonium acetate/formate) and adjust pH to optimize chromatographic performance and analyte stability. No specific buffer system is defined for this item.
Green Alternatives
Context
As an impurity standard, the principal environmental impact arises from solvent usage in analytical workflows rather than from the standard itself. Optimization can significantly reduce waste without compromising data quality.
Greener method choices (general; not item-specific)
Mobile phases: Prefer water/ethanol or water/acetone systems where chromatographically feasible; however, acetonitrile or methanol often remain necessary for resolution and MS compatibility. Evaluate isocratic vs shallow-gradient methods to shorten run times.
Buffering: Use low-concentration, volatile ammonium salts instead of phosphate buffers for LC–MS to avoid salt waste and enable solvent recovery.
Miniaturization: Adopt micro- or capillary-flow LC to cut solvent consumption by 5–20× while maintaining sensitivity.
SFC: Where analyte lipophilicity permits, supercritical CO2 with alcohol modifiers can reduce organic solvent usage and speed analyses.
Sample prep: Employ solid-phase extraction with minimal solvent elution volumes; select sorbents that enable aqueous loading and alcohol elution.
Trade-offs
Greener solvents can alter selectivity and sensitivity; method re-optimization (pH, temperature, gradient) is often required. Validate robustness, particularly for stability-indicating methods.
Pharmaceutical Uses
No therapeutic or clinical use. For research use only.
Applicable role (general for impurity standards):
Reference and system suitability standard for pharmaceutical quality control of sofosbuvir drug substance/product.
Utilized during method development, validation (linearity, accuracy, precision, specificity), and routine release/stability testing in accordance with ICH guidelines (e.g., Q3A/B for impurities, Q2(R2) for analytical validation).
Supports identification and tracking of process- or storage-related impurity profiles across manufacturing lots.
Note: Any GMP use requires qualification of the reference standard, documented traceability, and alignment with internal SOPs and regulatory expectations. This item’s specific grade/purity is not specified; consult the CoA before use in regulated environments.
Physical Properties
Item-specific data
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
SMILES/InChI: Not specified for this item; refer to CoA/Spec Sheet.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point, boiling point, density, refractive index, logP, pKa: Not specified for this item; refer to CoA/Spec Sheet.
General properties of sofosbuvir-related impurities (literature/context; not item-specific)
Many nucleoside phosphoramidate analogs are polar, often existing as crystalline solids at ambient temperature.
Solubility trends: typically soluble in highly polar aprotic solvents (DMSO, DMF, NMP) and polar protic solvents (methanol, ethanol) to varying degrees; aqueous solubility can be limited unless ionizable phosphate-like groups are present or pH is adjusted.
Ionization: phosphate/phosphoramidate functionalities may display multiple pKa values (acidic P–OH/phosphate) enabling pH-dependent solubility; exact pKa values are structure-dependent and are not available for this item.
Thermal behavior: nucleoside-like compounds can exhibit decomposition before boiling; thermogravimetric stability depends on protecting groups and hydration state.
Note: In the absence of item-specific characterization, users should determine solubility and stability empirically on a small scale, and rely on the product CoA/SDS for authoritative specifications.
Quality and Grades
Item-specific quality information
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting grades for impurity/reference standards (general guidance)
Impurity and reference standards are typically supplied at high chemical purity with verified identity (NMR, MS, HPLC/UPLC). When provided, chromatographic purity thresholds (e.g., ≥95% or ≥98%) indicate the proportion of the main component by area normalization; confirmation requires the vendor CoA.
Documentation: Expect a Certificate of Analysis detailing identity tests (1H/13C NMR, MS), chromatographic purity method/conditions, residual solvent profile (when available), and storage conditions.
If a stabilizer is present (not specified for this item), it will be disclosed on the CoA; stabilizers can affect UV background and MS response in analytical methods and should be considered during method development.
Trace-level attributes (water content, residual solvents, metal content, UV cutoff) are method- and item-dependent; because these are not specified for this item, consult the CoA or request additional information if these parameters are critical for your application.
For GMP/QC use, ensure traceability by recording lot numbers and maintaining CoA copies within your quality system.
Reaction and Applications
Item-specific application focus
This product is intended as a research-use impurity standard associated with sofosbuvir. No specific synthetic application is provided in the Product Data.
Typical applications for API impurity standards (general; not item-specific)
Analytical reference: Use as a reference standard for method development and validation of HPLC/UPLC, LC–MS/MS, and stability-indicating assays for sofosbuvir drug substance or formulations.
System suitability: Evaluate resolution, tailing, and sensitivity near the retention region of the target impurity to confirm chromatographic performance.
Calibration/quantitation: Prepare multi-level calibration curves to support limit tests or quantitative impurity profiling in accordance with ICH Q2(R2).
Forced degradation mapping: Aid peak tracking during acid/base, oxidative, thermal, and photolytic stress studies to confirm specificity.
Metabolite/variant tracking: Although not a biological reagent, structurally related impurities can assist in assigning peaks that arise from process variations or storage conditions.
Practical notes
Confirm identity with orthogonal methods (HRMS, NMR) upon receipt, especially for critical validation lots.
Assess solution stability in intended diluents (autosampler at 4–10°C vs ambient) and light sensitivity; use amber vials if necessary.
For LC–MS, favor volatile buffers (ammonium formate/acetate) and moderate pH to balance ionization and stability.
Reaction Conditions
Not directly applicable to this item as a reference/impurity standard.
Analytical method conditions (general, literature-informed; not item-specific):
RP-HPLC/UPLC: C18 column, 30–60% organic over 5–20 min; organic phase MeCN or MeOH; aqueous phase water with 5–20 mM ammonium formate/acetate, pH 3–6 (formic acid) or pH 7–9 (ammonia) depending on analyte stability and ionization.
LC–MS/MS: ESI± depending on phosphate group ionization; typical source 300–450°C, curtain/sheath gases adjusted to minimize in-source fragmentation. Employ low ionic strength buffers for sensitivity.
Stability checks: Evaluate autosampler stability at 4–10°C for 24–72 h and bench-top stability at ambient for sample preparation windows; confirm with replicate injections.
These are general starting points; optimize to the specific impurity once structural and chromatographic behavior are confirmed.
Safety and Handling
Item-specific hazard information
Signal Word: Not specified for this item; refer to SDS.
H-Statements: Not specified for this item; refer to SDS.
GHS Classification: Not specified for this item; refer to SDS.
Pictograms: Not specified for this item; refer to SDS.
General laboratory precautions for small-molecule impurity standards (not item-specific)
Handle in a chemical fume hood with appropriate PPE: lab coat, safety glasses, and suitable chemically resistant gloves (e.g., nitrile). Avoid inhalation of dust and contact with skin/eyes.
Avoid exposure to moisture and strong acids/bases that may hydrolyze phosphoramidate/phosphate-like functionalities common in sofosbuvir-related structures.
Incompatibilities: strong oxidizers/reductants may degrade organic impurities; avoid prolonged light exposure and elevated temperatures that can promote degradation.
First aid (general): in case of skin or eye contact, rinse with water for at least 15 minutes; if inhaled, move to fresh air; if ingested, rinse mouth. Seek medical attention according to institutional policies. Always consult the SDS for authoritative guidance.
Spill response: minimize dust generation; collect with inert absorbent, place in appropriate waste. Decontaminate area with solvent compatible with your lab’s waste procedures.
Always defer to the product’s SDS and institutional EHS guidance for risk assessment and handling practices.
Solvent Selection
Item-specific note
Solubility profile is not specified for this item; perform a micro-scale solubility screen. Common starting solvents for nucleoside-like impurities include DMSO, DMF, methanol, ethanol, acetonitrile, and mixtures with water or buffers.
General guidance (not item-specific)
Polarity: Sofosbuvir-related impurities often exhibit moderate-to-high polarity. Polar aprotic solvents (DMSO, DMF, NMP, acetonitrile) frequently provide good solubility and LC–MS compatibility.
Aqueous systems: For phosphate/phosphoramidate species, modest pH adjustment (e.g., pH 7–9 with ammonium bicarbonate or ammonium acetate) can enhance solubility while remaining MS-friendly.
Volatile systems for prep: Acetonitrile/water or methanol/water are preferred for RP-HPLC. For normal-phase or SFC, consider alcohol modifiers with CO2 if the compound is sufficiently lipophilic.
Comparison overview (general)
DMSO vs DMF: DMSO superior for stock solutions and bioanalytical compatibility; DMF may better dissolve certain salts but is less desirable in bioassays.
MeOH vs MeCN: MeOH offers stronger elution and hydrogen bonding; MeCN provides lower viscosity, better LC pressures, and broader detector linearity.
Always filter stock solutions (0.2 µm PTFE/RC) to remove particulates and confirm stability by test injections before scale-up.
Storage and Reconstitution
Item-specific storage
Storage Conditions: Store at -20°C (from Product Data).
Shipping: Shipped in ice chest with ice pads (from Product Data).
General handling and reconstitution guidance (not item-specific)
Upon receipt: Allow container to equilibrate to room temperature in a desiccator before opening to prevent moisture condensation.
Reconstitution: Because solubility for this item is not specified, perform a small-scale test in dry DMSO, methanol, ethanol, or acetonitrile. If needed, use mixed solvents (e.g., MeCN:H2O or MeOH:H2O) and adjust pH with volatile buffers compatible with your analytical method. Document solvent composition on vial labels.
Aliquoting: Prepare single-use aliquots to minimize freeze–thaw cycles. Store aliquots at -20°C (or lower if stability data indicate), protected from light and moisture.
Stability: Without item-specific data, assume limited solution stability. Verify by periodic analytical checks (e.g., LC–MS purity, UV profile) and discard if degradation is observed.
Container: Use amber glass vials with PTFE-lined caps. Purge headspace with inert gas if the analyte is oxidation-sensitive.
Always refer to the product CoA/SDS for definitive stability, solubility, and shelf-life information.
Structure and Identity
Item-specific facts (from Product Data)
Product name: Sofosbuvir impurity I (SKU: S650041)
CAS: 2164516-85-0
PubChem CID: 145714361
InChIKey: 128955 (as provided; note that standard InChIKeys are typically 27 characters—refer to CoA/SDS for confirmation)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Context and structural considerations (general/literature context, not item-specific)
“Sofosbuvir impurity I” denotes a structurally related process/degradant impurity associated with the nucleotide prodrug sofosbuvir. Such impurities commonly derive from transformations of the nucleoside core, the phosphoramidate promoiety, or protecting-group variants. However, the precise structure of “impurity I” varies by synthetic route and is not specified here.
Typical structural motifs in sofosbuvir-related impurities can include: modified ribose/furanose nucleoside frameworks, substituted uracil-like bases, and P(V) phosphoramidate/phosphate groups with aryl/alkoxy substituents. Stereochemical integrity at the nucleoside C1' center and at phosphorus may be relevant for analytical discrimination.
2D structural description (general, illustrative only; not for this item)
Nucleoside-derived impurities often feature a heteroaromatic base linked via a N-glycosidic bond to a ribose-like ring, bearing a phosphoramidate or phosphate substituent on the 5'-position; variations include des‑isopropyl, deprotected, hydrolyzed, or epimerized derivatives. For the exact blueprint of this item, consult the product CoA.
Synthetic Utility
This product is provided as an impurity standard and is not primarily intended as a synthetic building block.
General context (not item-specific):
Nucleoside- and phosphoramidate-like impurities can inform retrosynthetic analysis and route optimization by revealing side-reaction pathways (e.g., hydrolysis of phosphoramidates, epimerization at P, glycosidic bond cleavage, or protecting group migration). Studying these species helps chemists refine coupling conditions, reagent choices, and protecting-group strategies during API synthesis.
Mechanistic insights: Observation of particular impurity classes can implicate reaction conditions (acid/base strength, water content, temperature) and the roles of catalysts or activating agents in undesired pathways.
If considering this material as a synthetic comparator or reference, verify its exact structure and functional groups from the CoA before extrapolating reactivity.
Target Specificity
Not applicable. This product is a small-molecule impurity standard and does not have biological target specificity, antibody isotype, clone, or species reactivity.
Foire aux questions
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2164516-85-0, the molecular formula is C21H27FN3O9P, and the molecular weight is 515.43 g/mol. InChIKey HRGZELWFPQCNNG-SIBYKXJYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.